There are new quality measures coming to the Inpatient Psychiatric Facilities Quality Reporting (IPFQR ) Program beginning with Jan. 1, 2015 discharges. The measures cover tobacco use and immunization and also include three new claims-based measures.
Three New Claims-Based Measures
- FUH: Follow-Up After Hospitalization for Mental Illness
- Assessment of Patient Experience of Care
- Use of Electronic Health Record
Two new Immunization Measures:
- IMM-2 – Addresses patients discharged during the 2015-2016 flue season (beginning Oct. 2015-March 2016) six months and older who were screened for seasonal influenza immunization status and were vaccinated prior to discharge if indicated.
- Influenza Vaccination Coverage Among health Care Personnel (HCP)—The HCP Influenza Vaccination measure is designed to ensure that reported HCP influenza vaccination percentages are consistent over time within a single healthcare facility and comparable across facilities. Data are entered into the Centers for Disease Control and Prevention’s (CDC’s) National Healthcare Safety Network (NHSN)
Three new Tobacco Measures:
- TOB-1: Tobacco Use Screening—Hospitalized patients screened within first 3 days of admission for tobacco use within the past 30 days. Tobacco use includes all forms of tobacco including cigarettes, smokeless tobacco products, pipes and cigars. A tobacco use screen should identify the type of tobacco product used, the volume used and the timeframe.
- TOB-2: Tobacco Use Treatment Provided or Offered— Patients identified as tobacco product users within past 30 days who receive or refuse practical counseling to quit AND receive or refuse FDA-approved cessation medications during the first three days after admission.
- TOB-2a: Tobacco Use Treatment—Patients who received counseling AND medication as well as those who received counseling and had a reason for not receiving the medication during the first three days after admission.
Difference between TOB-2 and TOB-2a—TOB-2 includes all patients who were offered and received OR offered and refused cessation medication (if indicated) and practical counseling. TOB-2a includes only those patients who were offered and ACTUALLY RECEIVED the cessation medication (if indicated) and the practical counseling.
Reason for no Tobacco Cessation Medication During the Hospital Stay (for TOB-2 and TOB-2a) These will include Allergy to all of the FDA-approved tobacco cessation medication, Drug interaction (for all of the FDA approved medications) with other drugs the patient is currently taking, and Other reasons documented by Physician, APN, PA, or Pharmacist.
FMQAI/HSAG, the Hospital Inpatient Value, Incentives and Quality Reporting Outreach and Education Support Contractor, recently published two Inpatient Pyschiatric Facilities Quality Reporting resources to assist you in your efforts to report your hospitals IPF quality data in a timely manner. Those resources include:
- IPFQR Timeline – one-page grid for collection and submission timelines for FY 2016 and FY 2017.
- IPFQR Measures for Fiscal Year (FY) 2016 and FY 2017 and Population and Sampling – provides measure-specific reporting period, submission period, type, sampling information and public display date.